欧州連合 - デンマーク語 - EMA (European Medicines Agency)

accord healthcare s.l.u. - icatibant acetate - angioødemer, arvelige - other hematological agents - icatibant accord is indicated for symptomatic treatment of acute attacks of hereditary angioedema (hae) in adults, adolescents and children aged 2 years and older, with c1 esterase inhibitor deficiency.

デンマーク - デンマーク語 - Lægemiddelstyrelsen (Danish Medicines Agency)

newbury pharmaceuticals ab - icatibant - injektionsvæske, opløsning i fyldt injektionssprøjte - 30 mg

デンマーク - デンマーク語 - Lægemiddelstyrelsen (Danish Medicines Agency)

actavis group ptc ehf. - ciclosporin - kapsler, bløde - 100 mg

デンマーク - デンマーク語 - Lægemiddelstyrelsen (Danish Medicines Agency)

actavis group ptc ehf. - ciclosporin - kapsler, bløde - 25 mg

デンマーク - デンマーク語 - Lægemiddelstyrelsen (Danish Medicines Agency)

actavis group ptc ehf. - ciclosporin - kapsler, bløde - 50 mg

デンマーク - デンマーク語 - Lægemiddelstyrelsen (Danish Medicines Agency)

laboratoire aguettant - icatibant - injektionsvæske, opløsning i fyldt injektionssprøjte - 30 mg

デンマーク - デンマーク語 - Lægemiddelstyrelsen (Danish Medicines Agency)

sun pharmaceutical industries europe bv - icatibant - injektionsvæske, opløsning i fyldt injektionssprøjte - 30 mg

欧州連合 - デンマーク語 - EMA (European Medicines Agency)

novartis europharm limited - indacaterol, glycopyrronium bromide, mometasone - astma - medicin for obstruktiv sygdomme, - enerzair breezhaler is indicated as a maintenance treatment of asthma in adult patients not adequately controlled with a maintenance combination of a long acting beta2 agonist and a high dose of an inhaled corticosteroid who experienced one or more asthma exacerbations in the previous year.

欧州連合 - デンマーク語 - EMA (European Medicines Agency)

novartis europharm limited  - indacaterol, mometasone furoate - astma - medicin for obstruktiv sygdomme, - bemrist breezhaler is indicated as a maintenance   treatment of asthma in adults and adolescents 12 years of age and older not adequately controlled with inhaled corticosteroids and inhaled short acting beta2-agonists.

欧州連合 - デンマーク語 - EMA (European Medicines Agency)

novartis europharm limited  - indacaterol acetate, mometasone furoate - astma - medicin for obstruktiv sygdomme, - atectura breezhaler is indicated as a maintenance treatment of asthma in adults and adolescents 12 years of age and older not adequately controlled with inhaled corticosteroids and inhaled short acting beta2-agonists.